ELTX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 19:20):
Our systems believe the stock currently is overvalued by -0.02% compare to its pairs and should correct downwards.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases...

Stats
आज की मात्रा	648
औसत मात्रा	46 933
बाजार मूल्य	69.22M
EPS	$-1.150 ( Q1 \| 2024-03-31 )
अगली कमाई की तारीख	( $-0.960 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0380 (0.56%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.37%

ABIO -1.68%

ABOS 1.64%

ABSI 2.89%

ABUS -2.24%

ABVX -3.53%

ACAD -0.45%

ACER -17.95%

ACET -4.44%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -0.50%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.59%

ADPT -0.30%

ADTX -3.47%

ADVM -4.29%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.32%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.25%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.46%

ALLR -3.91%

ALNA 3.16%

ALNY 1.72%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.38%

ALVR -0.57%

ALXN 0.00%

ALXO -10.43%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.07%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.86%

ARDS -14.23%

ARDX -0.91%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.86%

ASLN -4.71%

ASMB -5.19%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -22.52%

BCYC 0.55%

BDRX -5.14%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 1.18%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.60%

BMRN 0.39%

BNOX -2.22%

BNTC -2.11%

BNTX -1.25%

BOLD -7.90%

BOLT -0.18%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.18%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.28%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA -0.63%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.41%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.48%

CELC -3.85%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.82%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -2.79%

CGON -0.29%

CGTX -4.55%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING -3.70%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.51%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.89%

CORT 2.17%

COYA -1.46%

CPRX -0.76%

CRBP -1.85%

CRBU -4.83%

CRDF -2.21%

CRGX 1.28%

CRIS -0.38%

CRNX -5.96%

CRSP 1.04%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.28%

CTNM -0.65%

CTXR 0.04%

CUE 3.63%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.06%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 34.47%

DNLI -1.92%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -8.05%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.77%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.47%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.98%

GHRS -1.60%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.82%

GOVX 3.65%

GOVXW -49.04%

GPCR -7.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.83%

HRTX 1.80%

HSTO 0.00%

HUMA 1.22%

HUMAW -0.01%

IBRX -4.26%

ICCC 0.22%

ICPT 0.21%

ICU 17.92%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -2.66%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.68%

INAB 0.59%

INBX 0.47%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.56%

INSM -0.88%

INTS -2.75%

INVA 0.22%

INZY 1.15%

IOBT -11.02%

IONS 0.04%

IOVA -2.25%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.22%

JAZZ -0.55%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 16.29%

KTTA 8.16%

KTTAW 0.92%

KURA -1.78%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.93%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.78%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.50%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.92%

LYRA 2.71%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -2.91%

MGTA -7.74%

MGTX -2.68%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.55%

MNKD -1.05%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.67%

MREO -4.43%

MRKR 2.68%

MRNA -5.04%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.25%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.98%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.46%

NMTR -42.97%

NOVN -24.84%

NRBO 10.92%

NRIX -0.58%

NRSN -3.63%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.27%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.93%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 3.36%

OCS -1.02%

OCUL -1.91%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.12%

OMER -0.90%

OMGA 5.41%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.35%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.11%

PEPG 0.48%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.95%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.61%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.84%

QSIAW -3.13%

QTTB -4.54%

QURE -0.45%

RAIN -1.63%

RANI 6.42%

RAPT -2.29%

RARE 1.10%

RCKT -8.09%

REGN -0.66%

RENB -3.11%

REPL -2.82%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.59%

RLMD 0.33%

RLYB -0.34%

RNA -0.42%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.46%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -4.15%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.14%

SGMT -2.12%

SGTX -2.56%

SIOX 22.63%

SLDB -5.00%

SLGL 4.00%

SLN -4.21%

SLNO -2.71%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.77%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.86%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.80%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.29%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.12%

TBPH 0.54%

TCBP 2.73%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.19%

TENX -1.27%

TERN -7.59%

TFFP -3.05%

TGTX -2.71%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.35%

TNYA -8.76%

TPST 2.30%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.89%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -7.38%

UBX -2.12%

UNCY -3.38%

URGN -1.45%

UTHR -0.25%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.81%

VERU 0.78%

VERV -2.86%

VIGL 5.11%

VINC 1.62%

VIR 0.43%

VIRI -1.57%

VIRX 2.40%

VKTX -1.34%

VLON -13.04%

VNDA -2.36%

VOR -2.42%

VRCA 0.28%

VRDN -4.23%

VRNA -1.00%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.78%

XCUR 3.58%

XENE -2.91%

XERS 2.62%

XFOR 3.71%

XLO 1.58%

XLRN 0.00%

XNCR 0.34%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.71%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.48%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Chudnovsky Yekaterina	Buy	1 032 702	Pre-Funded Common Stock Purchase Warrant
2024-02-01	Piekos Brian	Buy	43 225	Stock Option (right to buy)
2024-02-01	Connelly Robert	Buy	225 137	Stock Option (right to buy)
2024-02-01	Haqq Christopher	Buy	28 200	Stock Option (right to buy)
2024-02-01	Demuth Peter	Buy	29 800	Stock Option (right to buy)

INSIDER POWER
100.00
Last 6 transactions
Buy: 1 359 406 \| Sell: 0

सहसंबंध (AI algo v.1.1b): Overvalued: -0.02% $6.74 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Elicio Therapeutics, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Elicio Therapeutics, Inc. वित्तीय

Annual	2022
राजस्व:	$0
सकल लाभ:	$0 (0.00 %)
EPS:	$-88.84

FY	2022
राजस्व:	$0
सकल लाभ:	$0 (0.00 %)
EPS:	$-88.84

FY	2020
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.930

FY	2019
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.505

Financial Reports:

No articles found.

Elicio Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company\'s lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.